v3 Template
S

Seelos Therapeutics, Inc.

Biotechnology / Healthcare ~120 employees
Founded
--
Employees (Est.)
~120
8 leaders known
Total Funding
$4.0M
Funding Rounds
1
Last Funding
2024-01-26

About Seelos Therapeutics, Inc.

Seelos Therapeutics, Inc. is a company focused on achieving the most efficient development of products that address significant unmet needs in central nervous system (CNS) disorders and rare diseases.

Products & Services

SLS-002 (intranasal ketamine):A treatment targeting Acute Suicidal Ideation and Behavior (ASIB) in Major Depressive Disorder (MDD) and Post-Traumatic Stress Disorder (PTSD).
SLS-004 (gene therapy):A gene therapy product under development.
SLS-005 (intravenous trehalose):An intravenous treatment, part of initiatives like the HEALEY ALS Platform Trial for amyotrophic lateral sclerosis (ALS).
SLS-007 (peptidic inhibitor):A peptidic inhibitor product in the pipeline.
SLS-009 (protein targeted autophagy):A product focused on protein-targeted autophagy.
STRIDES-SCA:A program aimed at treating Spinocerebellar Ataxia (SCA).

Specialties

Central Nervous System (CNS) disorders Rare diseases Intranasal ketamine therapy Gene therapy Intravenous trehalose treatment Peptidic inhibitors Protein-targeted autophagy

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Registered Direct Offering and Concurrent Private Placement
T: -
FT: Registered Direct Offering and Concurrent Private Placement
A: 4000000
MR: -
FA: approximately $4.0 million
FAN: 4000000
D: 2024-01-26
FD: 2024-01-26
1 investors
Registered Direct Offering and Concurrent Private Placement Latest
2024-01-26
$4.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

R

Raj Mehra

Chairman, Founder, and Chief Executive Officer

R

Richard W. Pascoe

Chairman of Seelos Therapeutics, Inc.

M

Margaret Dalesandro

Founder and President

B

Brian Lian

CEO and President

M

Michael Golembiewski

Chief Financial Officer

K

Karen Fusaro

SVP Head of Clinical Operations

View 5 more team members with Pro

Unlock Full Team Directory

Recent News

Seelos Therapeutics, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~120 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro